首页> 外文期刊>Journal of cellular and molecular medicine. >RNomic identification and evaluation of npcTB_6715, a non‐protein‐coding RNA gene as a potential biomarker for the detection of Mycobacterium tuberculosis
【24h】

RNomic identification and evaluation of npcTB_6715, a non‐protein‐coding RNA gene as a potential biomarker for the detection of Mycobacterium tuberculosis

机译:Rnomic鉴定和评估npcTB_6715,这是一种非蛋白质编码的RNA基因,可作为检测结核分枝杆菌的潜在生物标记

获取原文
           

摘要

Abstract Technological advances in RNA biology greatly improved transcriptome profiling during the last two decades. Besides the discovery of many s mall RNA s (sRNA) that are involved in the physiological and pathophysiological regulation of various cellular circuits, it becomes evident that the corresponding RNA genes might also serve as potential biomarkers to monitor the progression of disease and treatment. sRNA gene candidate npcTB_6715 was previously identified via experimental RNomic (unpublished data), and we report its application as potential biomarker for the detection of Mycobacterium tuberculosis (MTB) in patient samples. For proof of principle, we developed a multiplex PCR assay and report its validation with 500 clinical cultures, positive for Mycobacteria . The analysis revealed 98.9% sensitivity, 96.1% specificity, positive and negative predictive values of 98.6% and 96.8%, respectively. These results underscore the diagnostic value of the sRNA gene as diagnostic marker for the specific detection of MTB in clinical samples. Its successful application and the general ease of PCR-based detection compared to standard bacterial culture techniques might be the first step towards ‘point-of-care’ diagnostics of Mycobacteria . To the best of our knowledge, this is the first time for the design of diagnostic applications based on sRNA genes, in Mycobacteria .
机译:摘要在过去的二十年中,RNA生物学技术的进步极大地改善了转录组的分析。除了发现许多涉及各种细胞回路的生理和病理生理调控的购物中心RNA(sRNA)之外,很明显的是,相应的RNA基因也可能用作监测疾病和治疗进展的潜在生物标志物。 sRNA基因候选物npcTB_6715先前是通过实验性RNomic(未发表的数据)鉴定的,我们报告了其作为检测患者样品中结核分枝杆菌(MTB)的潜在生物标记物的应用。为证明原理,我们开发了一种多重PCR检测方法,并报告了对500种分枝杆菌呈阳性的临床培养物的验证。分析显示灵敏度为98.9%,特异性为96.1%,阳性和阴性预测值分别为98.6%和96.8%。这些结果强调了sRNA基因作为诊断标记物对临床样品中MTB特异性检测的诊断价值。与标准细菌培养技术相比,它的成功应用和基于PCR的检测的普遍简便性可能是迈向分枝杆菌“即时诊断”诊断的第一步。据我们所知,这是首次在分枝杆菌中基于sRNA基因设计诊断应用程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号